Quidel | QDEL - Los Gastos De Explotación





Los Gastos De Explotación Cambio Fecha
Abbott USD 10.46B 1.15B 2026-06
Agilent USD 1.43B 2M 2026-06
Becton, Dickinson and Co. USD 24.42B 283M 2026-06
Bruker USD 768.9M 44.3M 2026-06
Cerus USD 34.78M 2.98M 2024-12
Charles River Laboratories USD 2.84B 1.96B 2026-06
Danaher USD 52.58B 368M 2026-06
Haemonetics USD 145.34M 148.66M 2026-06
Illumina USD 899M 47M 2026-06
IQVIA Holdings USD 1.77B 4.45B 2026-06
Merit Medical Systems USD 358.44M 20.72M 2026-06
Mettler Toledo International USD 739.77M 26.57M 2026-06
Myriad Genetics USD 212.8M 16.2M 2025-12
Neogen USD 222.2M 7.7M 2026-03
OraSure Technologies USD 40.35M 2.45M 2025-12
Pacific Biosciences Of California USD 97.83M 41.29M 2025-12
Quidel USD 646.2M 1.21B 2026-06
Revvity USD 603.55M 24.8M 2026-06
STAAR Surgical USD 83.43M 7.32M 2026-06
Thermo Fisher Scientific USD 9.81B 716M 2026-06
Waters USD 527M 592M 2026-06